Aptose Biosciences Stock Buy Hold or Sell Recommendation
| APS Stock | CAD 0.27 0.07 20.59% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Aptose Biosciences is 'Strong Sell'. The recommendation algorithm takes into account all of Aptose Biosciences' available fundamental, technical, and predictive indicators you will find on this site.
Check out Aptose Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide. In addition, we conduct extensive research on individual companies such as Aptose and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Aptose |
Execute Aptose Biosciences Buy or Sell Advice
The Aptose recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aptose Biosciences. Macroaxis does not own or have any residual interests in Aptose Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aptose Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Aptose Biosciences Trading Alerts and Improvement Suggestions
| Aptose Biosciences generated a negative expected return over the last 90 days | |
| Aptose Biosciences has high historical volatility and very poor performance | |
| Aptose Biosciences has some characteristics of a very speculative penny stock | |
| Aptose Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (51.21 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Aptose Biosciences has accumulated about 36.37 M in cash with (44.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 16.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Aptose Biosciences Announces 8 Million Public Offering - TipRanks |
Aptose Biosciences current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aptose analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aptose analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Aptose Biosciences Returns Distribution Density
The distribution of Aptose Biosciences' historical returns is an attempt to chart the uncertainty of Aptose Biosciences' future price movements. The chart of the probability distribution of Aptose Biosciences daily returns describes the distribution of returns around its average expected value. We use Aptose Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aptose Biosciences returns is essential to provide solid investment advice for Aptose Biosciences.
| Mean Return | -1.16 | Value At Risk | -10.53 | Potential Upside | 5.66 | Standard Deviation | 5.54 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aptose Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aptose Biosciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 64.5M | 37.6M | (78.3M) | (2.1M) | (27.7M) | (26.3M) | |
| Free Cash Flow | (21.7M) | (34.0M) | (43.5M) | (32.3M) | (44.6M) | (42.4M) | |
| Depreciation | 613K | 614K | 622K | 528K | 466K | 565.2K | |
| Capital Expenditures | 102K | 79K | 212K | 24K | 29K | 27.6K | |
| Net Income | (26.3M) | (55.2M) | (65.4M) | (41.8M) | (51.2M) | (48.6M) | |
| End Period Cash Flow | 79.8M | 117.4M | 39.1M | 37.0M | 9.3M | 16.4M | |
| Other Non Cash Items | (55K) | (435K) | 7.0M | (551K) | (312K) | (296.4K) | |
| Investments | (17.3M) | 12.7M | (35.0M) | 30.1M | 10.0M | 10.5M | |
| Change To Netincome | 4.9M | 2.7M | 21.5M | 20.5M | 23.5M | 24.7M |
Aptose Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aptose Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aptose Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aptose stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.07 | |
β | Beta against Dow Jones | -0.79 | |
σ | Overall volatility | 5.32 | |
Ir | Information ratio | -0.23 |
Aptose Biosciences Volatility Alert
Aptose Biosciences exhibits very low volatility with skewness of -1.91 and kurtosis of 5.91. Aptose Biosciences is a potential penny stock. Although Aptose Biosciences may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Aptose Biosciences. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Aptose instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Aptose Biosciences Fundamentals Vs Peers
Comparing Aptose Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aptose Biosciences' direct or indirect competition across all of the common fundamentals between Aptose Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aptose Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aptose Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aptose Biosciences to competition |
| Fundamentals | Aptose Biosciences | Peer Average |
| Return On Equity | -6.94 | -0.31 |
| Return On Asset | -1.36 | -0.14 |
| Current Valuation | (3.86 M) | 16.62 B |
| Shares Outstanding | 19.52 M | 571.82 M |
| Shares Owned By Insiders | 15.87 % | 10.09 % |
| Shares Owned By Institutions | 16.68 % | 39.21 % |
| Number Of Shares Shorted | 2.25 K | 4.71 M |
| Price To Earning | (1.85) X | 28.72 X |
| Price To Book | 68.22 X | 9.51 X |
| EBITDA | (52.27 M) | 3.9 B |
| Net Income | (51.21 M) | 570.98 M |
| Cash And Equivalents | 36.37 M | 2.7 B |
| Cash Per Share | 0.64 X | 5.01 X |
| Total Debt | 1.01 M | 5.32 B |
| Debt To Equity | 5.00 % | 48.70 % |
| Current Ratio | 11.27 X | 2.16 X |
| Book Value Per Share | (0.36) X | 1.93 K |
| Cash Flow From Operations | (44.59 M) | 971.22 M |
| Short Ratio | 0.45 X | 4.00 X |
| Earnings Per Share | (4.08) X | 3.12 X |
| Target Price | 31.02 | |
| Number Of Employees | 35 | 18.84 K |
| Beta | 1.36 | -0.15 |
| Market Capitalization | 5.27 M | 19.03 B |
| Total Asset | 12.99 M | 29.47 B |
| Retained Earnings | (515.54 M) | 9.33 B |
| Working Capital | (3.38 M) | 1.48 B |
| Net Asset | 12.99 M |
Aptose Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aptose . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Aptose Biosciences Buy or Sell Advice
When is the right time to buy or sell Aptose Biosciences? Buying financial instruments such as Aptose Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aptose Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Social Domain Thematic Idea Now
Social Domain
New or established large and mid-sized companies that are involved in the social media industry, including entities that provide web-based or mobile media applications and services across across large segment of population in multiple geographical areas. The Social Domain theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Social Domain Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Aptose Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..